[Infective endocarditis prophylaxis in congenital heart disease]

Sylvie Di Filippo1

  • 1Université Claude-Bernard Lyon-1, hospices civils de Lyon, département médico-chirurgical de cardiologie pédiatrique et congénitale adulte, 28, avenue Doyen-Lépine, 69677 Lyon cedex, France.

Presse Medicale (Paris, France : 1983)
|June 4, 2017
PubMed

Insights

New guidelines for infective endocarditis prophylaxis exclude many at-risk patients, leading to physician non-adherence. Current recommendations for preventing infective endocarditis in congenital heart disease patients need revision.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Infective endocarditis (IE) poses a significant risk for patients with congenital heart disease (CHD), contributing to substantial mortality.
  • Current IE prophylaxis guidelines have shifted focus away from certain CHD conditions, such as native shunts and valvular disease.

Purpose of the Study:

  • To evaluate the impact of new IE prophylaxis guidelines on clinical practice and IE incidence.
  • To advocate for the inclusion of high-velocity shunts, like ventricular septal defects, in IE prophylaxis recommendations for CHD patients.

Main Methods:

  • Analysis of adherence to new IE prophylaxis guidelines among healthcare providers.
  • Review of IE incidence rates following the implementation of updated guidelines.

Main Results:

  • Over 50% of physicians are not adhering to the new IE prophylaxis guidelines.
  • The updated guidelines have not demonstrably reduced the incidence of infective endocarditis.
  • High-velocity shunts, such as ventricular septal defects, are proposed as critical targets for IE prophylaxis in CHD.

Conclusions:

  • Current IE prophylaxis guidelines may be insufficient, failing to adequately protect all at-risk CHD populations.
  • Physician non-adherence suggests a perceived gap between guidelines and clinical necessity.
  • Revising guidelines to include specific high-risk CHD features like high-velocity shunts is crucial for effective IE prevention.

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
612
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
292
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
476
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
422
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
642
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
551